¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contact compound scanner"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • allergic contact dermatitis
    ¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • contact
    1. Á¢ÃË- 2. Á¢ÃË
  • contact blepharitis
    Á¢ÃË´«²¨Ç®¿°, Á¢Ã˾Ȱ˿°
  • contact cheilitis
    Á¢ÃËÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È
  • contact dermatitis
    Á¢ÃËÇǺο°
  • contact gunshot wound
    Á¢»çÃÑ»ó
  • contact hypersensitivity
    Á¢Ã˰ú¹Î(Áõ)
  • contact immunotherapy
    Á¢Ã˸鿪¿ä¹ý
  • contact infection
    Á¢Ã˰¨¿°
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • contact irradiation
    Á¢ÃËÁ¶»ç¹ý
  • contact lens
    ÄÜÅÃÆ®·»Áî, Á¢ÃË·»Áî
  • contact media
    Á¢Ã˸Ű³¹°
  • contact radiography
    ±ÙÁ¢¹æ»ç¼±ÃÔ¿µ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact blepharitis
    Á¢ÃË´«²¨Ç®¿°
  • contact
    Á¢ÃË, Á¢ÃË-
  • contact cheilitis
    Á¢ÃËÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È
  • contact dermatitis
    Á¢ÃËÇǺο°
  • contact hypersensitivity
    Á¢Ã˰ú¹Î
  • contact immunotherapy
    Á¢Ã˸鿪¿ä¹ý
  • contact infection
    Á¢Ã˰¨¿°
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • contact irradiation
    Á¢ÃËÁ¶»ç¹ý
  • contact lens
    ÄÜÅÃÆ®·»Áî, Á¢ÃË·»Áî
  • contact media
    Á¢Ã˸Ű³¹°
  • contact radiography
    ±ÙÁ¢ÃÔ¿µ¼ú
  • contact scan
    Á¢Ã˽ºÄµ
  • contact scanning
    Á¢Ã˽ºÄ³´×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proximal contact
    ÀÎÁ¢(ìäïÈ).
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • heme compound
    ÇðÈ­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°.
  • heteropolar compound
    ÀÌ(¼º)±ØÈ­ÇÕ¹°(ì¶àõпûùùêÚª).
  • homeopolar compound
    µ¿±ØÈ­ÇÕ¹°.
  • homocyclic compound
    µ¿¼Òȯ½ÄÈ­ÇÕ¹°.
  • homopolar compound
    µ¿±ØÈ­ÇÕ¹°(ÔÒпûùùêÚª).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phased array scanner
    À§»ó ¹è¿­ ½ºÄ³³Ê
  • resistive MR scanner
    ÀúÇ× ÀÚ±â°ø¸í½ºÄ³³Ê
  • scanner
    ½ºÄ³³Ê
  • scanner
    ÃÊÀ½ÆÄ±â±â (õ±ëå÷îÐïѦ), ½ºÄ³³Ê
  • scanner
    ¹æ»ç ½ºÄ³³Ê.
  • sector scanner
    ºÎä²Ã ÃÊÀ½ÆÄ ±â±â (õ±ëå÷î ÐïѦ)
  • sector scanner
    ºÎä²Ã ½ºÄ³³Ê
  • super high field MR scanner
    ÃʰíÀÚÀå MR ½ºÄ³³Ê, ÃʰíÀÚÀå ÀÚ±â°ø¸í?
  • superconducting MR scanner
    ÃÊÀüµµ MR ½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • water bath scanner
    ¼öÁ¶½Ä (â©ðËãÒ) ½ºÄ³³Ê
  • water bath scanner
    ¼öÁ¶½Ä ½ºÄ³³Ê
  • affective contact
    Á¤µ¿Àû Á¢ÃË(¡­ïÈõº).
  • allergic contact dermatitis
    ¾Ë·¹¸£±â Á¢ÃËÇǺο°( ïÈõºù«Ý±æú)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • compound microscope
    º¹ÇÕÇö¹Ì°æ(ÜÜùêúéÚ°Ìð)
  • diazo compound
    µð¾ÆÁ¶ È­ÇÕ¹°(ûùùêÚª)
  • diazonium compound
    µð¾ÆÁ¶´½ È­ÇÕ¹°(ûùùêÚª) (ÔÒ) diazonium salt
  • energy-poor compound
    ºó(Þ¸)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • energy-rich compound
    ºÎ(Ý£)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • Kendall's compound
    ÄË´Þ È­ÇÕ¹°(ûùùêÚª)
  • labeled compound
    Ç¥ÁöÈ­ÇÕ¹°(øöò½ûùùêÚª)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • meso compound
    ¸Þ¼ÒÈ­ÇÕ¹°(ûùùêÚª)
  • nodal compound
    ¿ËÀÌ È­ÇÕ¹°(ûùùêÚª)
  • prochiral compound
    ۶ö Àü±¸È­ÇÕ¹°(îñÏÌûùùêÚª)
  • quaternary ammonium compound
    »çÂ÷(ÞÌó­) ¾Ï¸ð´Ï¾ÆÈ­ÇÕ¹°(ûùùêÚª).
  • Reichstein's compound
    ¶óÀÌÅ©½ºÅ¸ÀÎ È­ÇÕ¹°(ûùùêÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear electronic scanner
    ¼±ÇüÀüÀڽĽºÄ³³Ê
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • mechanical sector scanner
    ±â°è½ÄºÎä²Ã½ºÄ³³Ê
  • midfield MR scanner
    ÁßÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • phased array scanner
    À§»ó¹è¿­½ºÄ³³Ê
  • resistive MR scanner
    ÀúÇ×ÀÚ±â°ø¸í½ºÄ³³Ê
  • scanner
    ½ºÄ³³Ê
  • sector scanner
    ºÎä²Ã½ºÄ³³Ê
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • superconducting MR scanner
    ÃÊÀüµµMR½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • water bath scanner
    ¼öÁ¶½Ä½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCMCT Sperm Cervical Mucus Contact Test
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
AECD allergic eczematous contact dermatitis
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
CGDE contact glow discharge electrolysis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OP organophosphorus compound
OLC Ouabainlike compound
OPIDN organophosphorous compound-induced delayed neurotoxicity
ACD Allergic contact dermatitis
CL Contact Lens
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • compound nevus
    º¹ÇÕ¼º ¸ð¹Ý, º¹ÇÕ ¸ð¹Ý
  • compound S
    º¹ÇÕü S
  • compound scan motion
    º¹ÇÕ ½ºÄµ ¿îµ¿
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
  • hydrated compound
    ¼öÈ­ È­ÇÕ¹°
  • impression compound
    Àλó¿ë ÄÞÆÄ¿îµå
    Àλó¿ë°ú Æ®·¹ÀÌ¿ëÀÌ ÀÖ°í, õ¿¬ ¼öÁö, ÇÕ¼º ¼öÁö µîÀ¸·Î µÇ¾î ¿­ °¡¼Ò¼ºÀ» °®´Â ÀλóÀç.
  • inorganic compound
    ¹«±â È­ÇÕ¹°
    ź¼Ò¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â È­ÇÕ¹°.
  • intermetallic compound
    ±Ý¼Ó°£ È­ÇÕ¹°
    ¼ººÐ ¿ø¼Ò°¡ °£´ÜÇÑ Á¤¼öºñ·Î °áÇÕÇϰí ÀÖ´Â ÇÕ±Ý.
  • modeling compound impression
    ¿¬¼ºÀç Àλó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
contact illumination Illumination of the eye by means of an instrument in contact with the cornea or bulbar conjunctiva.
Critical illumination, the precise focusing of the light source directly upon the object being examined.
Dark-field illumination, a procedure in which a black circular shield is used to block the majority of the vertically directed rays of light (e.g., the field is dark), and a circumferential, suitably angled, mirrored surface is used to direct the peripheral rays horizontally against the object, thereby reflecting the light vertically through the objective lens and along the optical axis; thus, the object is well illuminated in a contrasting dark background.
Synonym: dark-ground illumination.
(05 Mar 2000)
contact induced spreading The response in which contact between two epithelial cells leads to a stabilised contact and the increased spreading of the cells so that the area covered is greater than that covered by the two cells in isolation.
(18 Nov 1997)
contact inhibition The inhibition of continued growth and division of a cell or colony due to physical contact with other cells or colonies. The stopping of continued growth when a certain density of cells has been reached.
The momentary stopping of all movement when a mobile cell runs into another cell.
(09 Oct 1997)
contact inhibition of growth See: density dependent inhibition.
(18 Nov 1997)
contact inhibition of movement Reaction in which the direction of motion of a cell is altered following collision with another cell. In heterologous contacts both cell may respond (mutual inhibition) or only one (nonreciprocal). Type I contact inhibition involves paralysis of the locomotory machinery, Type II is a consequence of adhesive preference for the substratum rather than the dorsal surface of the other cell.
(18 Nov 1997)
contact inhibition of phagocytosis Phenomenon described in sheets of kidney epithelial cells that, when confluent, lose their weak phagocytic activity, probably because of a failure of adhesion of particles to the dorsal surface in the absence of ruffles.
(18 Nov 1997)
contact lens A lens that fits over the cornea and sclera or cornea only; used to correct refractive errors.
(05 Mar 2000)
contact lenses Curved shells of glass or plastic applied directly over the globe or cornea to correct refractive errors.
(12 Dec 1998)
contact lenses, extended-wear Hydrophilic contact lenses worn for an extended period or permanently.
(12 Dec 1998)
contact lenses, hydrophilic Soft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilised.
(12 Dec 1998)
contact lens solutions Sterile solutions used to clean and disinfect contact lenses.
(12 Dec 1998)
contact point That part of the proximal surface of a tooth which touches the adjacent tooth mesially or distally.
Synonym: contact point, point of proximal contact.
(05 Mar 2000)
contact rate <epidemiology> The rate at which susceptibles meet infecteds. Usually measured as individuals per unit time.
(05 Dec 1998)
contact sensitivity Allergic response to contact with irritant, usually a hypersensitivity.
(18 Nov 1997)
contact sites A Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • compound microscope
    º¹ÇÕÇö¹Ì°æ
  • compound number
    Á¦µî¼ö(µÑÀÌ»óÀÇ ´ÜÀ§·Î Ç¥½ÃµÇ´Â ¼ö)
  • compound personal pronoun
    º¹ÇÕ ÀÎĪ ´ë¸í»ç(ÀÎĪ ´ë¸í»ç µÚ¿¡ -self°¡ ºÙÀº °Í)
  • compound relative
    º¹ÇÕ°ü°è»ç
  • compound sentence
    Áß¹®(ÀýÀ» and,butµî µîÀ§ Á¢¼Ó»ç·Î ÀÌÀº ¹®Àå)
  • compound word
    º¹ÇÕ¾î;ÇÕ¼º¾î
  • compound-complex sentence
    Áߺ¹¹®(Á¾¼ÓÀýÀ» ÇϳªÀÌ»ó °¡Áø Áß¹®)
  • interstitia compound
    È­ ħÀÔÇüÈ­ÇÕ¹°
  • contact
    Á¢ÃË,±³Á¦,¿¬¶ôÇÏ´Ù,Á¢ÃËÇÏ´Ù
  • contact
    Á¢ÃË;¸Â´êÀ½(touching);±³Á¦;Ä£±³(associations)¿¬¶ô(À» ÃëÇÔ);¿¬ÁÙ(connection);Á¢ÃË;È¥¼±;»óÁ¢;Á¢ÃË;º¸±Õ¿ëÀÇÀÚ;Á¢ÃË(°¨);Á¢Àü;(ºñÇà±â¿¡ ÀÇÇÑ Áö»ó ÀüÁøºÎ´ë¿ÍÀÇ)¿¬¶ô;À°¾È¿¡ ÀÇÇÑ Áö»ó°üÂû;±³½Å;(»ó¾÷Àû¸ñÀûÀ¸·Î)±³¼·Çϰí ÀÖ´Â »ç¶÷;Á߰迪ÇÒÀ» ÇÒ¼öÀÖ´Â »ç¶÷;=CONTACT L
  • contact action
    Á¢ÃËÀÛ¿ë
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • contact approach
    À¯½Ã°è ÁøÀÔ
  • contact breaker
    (Àü·ùÀÇ) Â÷´Ü±â
  • contact catalysis
    Á¢ÃË(Ã˸Å)ÀÛ¿ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á